Non-coding RNAs and potential therapeutic targeting in cancer
Recent advances have begun to clarify the physiological and pathological roles of non-
coding RNAs (ncRNAs) in various diseases, including cancer. Among these, microRNAs …
coding RNAs (ncRNAs) in various diseases, including cancer. Among these, microRNAs …
i-Motif DNA: structural features and significance to cell biology
The i-motif represents a paradigmatic example of the wide structural versatility of nucleic
acids. In remarkable contrast to duplex DNA, i-motifs are four-stranded DNA structures held …
acids. In remarkable contrast to duplex DNA, i-motifs are four-stranded DNA structures held …
[HTML][HTML] Genomic, pathway network, and immunologic features distinguishing squamous carcinomas
JD Campbell, C Yau, R Bowlby, Y Liu, K Brennan… - Cell reports, 2018 - cell.com
Summary This integrated, multiplatform PanCancer Atlas study co-mapped and identified
distinguishing molecular features of squamous cell carcinomas (SCCs) from five sites …
distinguishing molecular features of squamous cell carcinomas (SCCs) from five sites …
Radiation resistance in head and neck squamous cell carcinoma: dire need for an appropriate sensitizer
MKND Hutchinson, M Mierzwa, NJ D'Silva - Oncogene, 2020 - nature.com
Radiation is a significant treatment for patients with head and neck cancer. Despite
advances to improve treatment, many tumors acquire radiation resistance resulting in poor …
advances to improve treatment, many tumors acquire radiation resistance resulting in poor …
Cancer chemoresistance and its mechanisms: Associated molecular factors and its regulatory role
S Kannampuzha, AV Gopalakrishnan - Medical Oncology, 2023 - Springer
Cancer therapy has advanced from tradition chemotherapy methods to targeted therapy,
novel drug delivery mechanisms, combination therapies etc. Although several novel …
novel drug delivery mechanisms, combination therapies etc. Although several novel …
TRIP13 is a protein-remodeling AAA+ ATPase that catalyzes MAD2 conformation switching
Q Ye, SC Rosenberg, A Moeller, JA Speir, TY Su… - Elife, 2015 - elifesciences.org
The AAA+ family ATPase TRIP13 is a key regulator of meiotic recombination and the spindle
assembly checkpoint, acting on signaling proteins of the conserved HORMA domain family …
assembly checkpoint, acting on signaling proteins of the conserved HORMA domain family …
Evolutionary dynamics and molecular mechanisms of HORMA domain protein signaling
Controlled assembly and disassembly of multi-protein complexes is central to cellular
signaling. Proteins of the widespread and functionally diverse HORMA family nucleate …
signaling. Proteins of the widespread and functionally diverse HORMA family nucleate …
ROS‐Mediated therapeutic strategy in Chemo‐/Radiotherapy of head and neck cancer
G Huang, ST Pan - Oxidative medicine and cellular longevity, 2020 - Wiley Online Library
Head and neck cancer is a highly genetic and metabolic heterogeneous collection of
malignancies of the lip, oral cavity, salivary glands, pharynx, esophagus, paranasal sinuses …
malignancies of the lip, oral cavity, salivary glands, pharynx, esophagus, paranasal sinuses …
TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis
G Zhang, Q Zhu, G Fu, J Hou, X Hu, J Cao… - British journal of …, 2019 - nature.com
Background Thyroid hormone receptor interactor 13 (TRIP13) is an AAA+ ATPase that plays
an important role in the mitotic checkpoint. TRIP13 is highly expressed in various human …
an important role in the mitotic checkpoint. TRIP13 is highly expressed in various human …
Trip13 depletion in liver cancer induces a lipogenic response contributing to Plin2‐dependent mitotic cell death
M Rios Garcia, B Meissburger, J Chan… - Advanced …, 2022 - Wiley Online Library
Aberrant energy metabolism and cell cycle regulation both critically contribute to malignant
cell growth and both processes represent targets for anticancer therapy. It is shown here that …
cell growth and both processes represent targets for anticancer therapy. It is shown here that …